1-4 of 4
Jean Henri Bouhris
Close
Sort by
Journal Articles

Conditioning Regimen Intensity and Donor Choice Do Not Impact Outcomes of Patients (pts) with Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in First Complete Remission (CR1): An EBMT Analysis

Razan Mohty, Myriam Labopin, Jean Henri Bouhris, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Anne Huynh, Eolia Brissot, Didier Blaise, Régis Peffault de Latour, Claude-Eric Bulabois, Eric Deconinck, Jakob Passweg, Edouard Forcade, Hélène Labussière-Wallet, Xavier Leleu, Anne-Lise Menard, Ali Bazarbachi, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 4876–4877.
https://doi.org/10.1182/blood-2022-165606
Published: 2022
Journal Articles

Randomized Phase 2 Trial of Lirilumab (anti-KIR monoclonal antibody, mAb) As Maintenance Treatment in Elderly Patients (pts) with Acute Myeloid Leukemia (AML): Results of the Effikir Trial

Norbert Vey, Pierre-Yves Dumas, MD, Christian Recher, MD PhD, Lauris Gastaud, MD, Bruno Lioure, MD, Claude-Eric Bulabois, MD, Cecile Pautas, Jean-Pierre Marolleau, MD PhD, Stéphane Leprêtre, MD, Emmanuel Raffoux, MD, Xavier Thomas, MD, Yosr Hicheri, Caroline Bonmati, MD, Bruno Quesnel, MD PhD, Philippe Rousselot, Sylvie Castaigne, MD PhD, Eric Jourdan, MD, Jean Valère Malfuson, Gaelle Guillerm, MD, Jean Henri Bouhris, Mario Ojeda, MD, Mathilde Hunault, MD PhD, Norbert Ifrah, MD PhD, Claude Gardin, MD PhD, Andre Delannoy, MD, Lucile Beautier, Carine Paturel, PhD, Pascale Andre, PhD, Robert Zerbib, Claude Preudhomme, PharmD, PhD, Antoine Toubert, MD PhD, Nicolas Dulphy, PhD, Daniel Olive, MD PhD, Arnaud Pigneux, MD, Herve Dombret, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 889.
https://doi.org/10.1182/blood.V130.Suppl_1.889.889
Published: 2017
Journal Articles

Skin Immune Stimulation By Infections and Drug Toxicities during Induction and/or Consolidations Increases Incidence of Skin Acute Graft Versus Host Disease in Acute Myeloid Leukemia: A Study on Behalf of SFGM-TC and ALFA

Lining Wang, Emmanuel Raffoux, MDPhD, Xavier Thomas, Ibrahim Yakoub-Agha, MD PhD, Jean Henri Bouhris, Stephane de Botton, Mauricette Michallet, MD PhD, Stephanie Nguyen quoc, MD, Sylvain P Chantepie, MD, Eric Deconinck, Denis Caillot, Pascal Turlure, MD, Stephane Vigouroux, Arnaud Pigneux, Anne Huynh, MD, Jean Valère Malfuson, MD, Michael Loschi, MD, Gerard Socie, Herve Dombret, MD, Regis Peffault de la Tour, MD PhD, Thomas Cluzeau, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1946.
https://doi.org/10.1182/blood.V126.23.1946.1946
Published: 2015
Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation (HSCT) in First Complete Remission Is Superior Compared to Chemotherapy/Autologous HSCT in Patients with Intermediate-Risk Cytogenetics Acute Myeloid Leukemia Lacking Mutations in NPM1 , FLT3 -ITD, and CEBPA : A Joint Study of AMLSG, Cetlam and Acute Leukemia Working Party of EBMT

Jordi Esteve, MD PhD, Myriam Labopin, MD, Marta Pratcorona, MD PhD, Felicitas Thol, MD, Salut Brunet, MD PhD, Michael Heuser, MD, Gudrun Göhring, PD, Arnold Ganser, MD PhD, Konstanze Döhner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Arnaud Pigneux, MD PhD, Gerard Socie, MD PhD, Jan J. Cornelissen, MD PhD, Michel Attal, Jean-Henri Bouhris, MD, Johan Maertens, MD, Didier Blaise, MD PhD, Mar Tormo, MDPhD, Josep-Maria Ribera, MD PhD, Marina Díaz-Beyá, MD PhD, Montserrat Hoyos, PhD, Jordi Sierra, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD, Hartmut Dohner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2014) 124 (21): 324.
https://doi.org/10.1182/blood.V124.21.324.324
Published: 2014